• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Data Market
    Data News
    Data Stocks
    • Data Market
    • Data News
    • Data Stocks

    Viratech Acquires 50% of Newswire.net, in Spin Off of Cancer.im, Inc.

    Written by Pia Rivera
    |
    Mar. 07, 2017 08:30AM PST

    Viratech (OTCPINK:VIRA) announced the acquisition of an additional 35,000,000 shares of common stock of Newswire, Inc., in exchange for all the issued and outstanding shares of Cancer.im, Inc. As quoted in the press release: “The Company’s efforts over the last 3 years have been focused on developing a social network platform, focused on capturing a multi …

    Viratech (OTCPINK:VIRA) announced the acquisition of an additional 35,000,000 shares of common stock of Newswire, Inc., in exchange for all the issued and outstanding shares of Cancer.im, Inc.
    As quoted in the press release:

    “The Company’s efforts over the last 3 years have been focused on developing a social network platform, focused on capturing a multi perspective point of view via verified and vetted social collaboration,” stated Fred Schiemann CEO of Viratech. “With this announcement we have hit a milestone; first with this transaction, we gain a partner in Newswire, where we hope to harness Newswire’s distribution platform to promote our News as a Utility (NaaU) Engine.
    “Second, we have achieved our Minimum Viable Product (MVP) threshold, on developing our first SNAP to reside on the www.cancer.imdomain on March 15, 2017. With the sale of Cancer.im, Inc. property, Viratech can now focus on developing new SNAP’s in the other health verticals. That is the beauty of software, once the infrastructure is built, replication into other health verticals becomes easier.”
    “Viratech has engineered an amazing tool-set for the cancer community, and starting March 15, 2017, I am excited that our team will be able to curate, manage and produce some of the most relevant content on the web pertaining to cancer research,” stated Chris Ryan CEO of Cancer.im, Inc.

    Click here for the full press release. 

    cancer research
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch

    Microscopic view of stem cells.

    Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

    Latest News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Data Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES